"Tumours rely on blood vessels to supply them with nutrients – we want to target these blood vessels in order to block tumour growth."
Biography
Dr Andrew Reynolds studied for his BSc in Molecular Cell Biology at the University of Southampton. He then moved to the Imperial Cancer Research Fund laboratories in London (now the Cancer Research UK London Research Institute) to undertake his PhD on growth factor receptor signalling. He then worked as a Postdoctoral Fellow at St. Thomas Hospital and St. Barts Hospital where he specialised in angiogenesis research. In 2007, he was awarded a Senior Fellowship by Breakthrough Breast Cancer to lead the Tumour Angiogenesis Group.
